Enliven Therapeutics, Inc. — 4/A Filings
10 4/A filings on record
This page lists all 4/A filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 10 4/A documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4/A | — | 0001415889-25-022649 | Aug 21, 2025 | Aug 18, 2025 |
| 4/A | — | 0001415889-24-004493 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | — | 0001415889-24-004490 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | — | 0001415889-24-004488 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | — | 0001415889-24-004486 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | — | 0001415889-24-004484 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | — | 0001415889-24-004482 | Feb 20, 2024 | Feb 13, 2024 |
| 4/A | FORM 4/A | 0001567619-23-000570 | Jan 5, 2023 | Jan 3, 2023 |
| 4/A | — | 0000947871-21-000798 | Jul 23, 2021 | Jul 16, 2021 |
| 4/A | — | 0000947871-21-000797 | Jul 23, 2021 | Jul 16, 2021 |